Individual sgRNA scores (log2) for UGDH in high and low DiI-LDL uptake populations from Karpas299 screen
Treatment selection is individualized and based on medical history, therapeutic goals, tolerability, and provider guidance
GLP-1 receptor agonists can support weight loss, stimulate insulin production, suppress the release of glucagon, slow digestion, boost the feeling of satiety, and reduce the risk of cardiac disease
A., Hhmer, A
What the Scientists Found When scientists dug deeper, they realized diabetes isnt just a matter of too much sugar. It sets off a cascade, like dominoes tipping into each other
We have evidence these products are potentially dangerous and can potentially lead to cancer, she says